ALDX vs BMRN · $112.2M cap vs P/E 40, rev $1.76B
Aldeyra The (ALDX) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Aldeyra The (ALDX) is a biotechnology company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
ALDX does not have a complete income-statement cache yet.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
ALDX currently screens at market cap $112.2M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the ALDX and BMRN stock pages for the full models.
Not investment advice.